SELLAS Life Sciences (SLS) EBT (2020 - 2023)
Historic EBT for SELLAS Life Sciences (SLS) over the last 7 years, with Q4 2023 value amounting to -$8.2 million.
- SELLAS Life Sciences' EBT rose 1343.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 972.82%. This contributed to the annual value of -$37.9 million for FY2023, which is 830.97% up from last year.
- According to the latest figures from Q4 2023, SELLAS Life Sciences' EBT is -$8.2 million, which was up 1343.43% from -$9.4 million recorded in Q3 2023.
- Over the past 5 years, SELLAS Life Sciences' EBT peaked at -$2.2 million during Q1 2021, and registered a low of -$16.7 million during Q1 2022.
- For the 4-year period, SELLAS Life Sciences' EBT averaged around -$7.6 million, with its median value being -$7.7 million (2022).
- In the last 5 years, SELLAS Life Sciences' EBT surged by 4475.89% in 2021 and then plummeted by 64543.43% in 2022.
- Over the past 4 years, SELLAS Life Sciences' EBT (Quarter) stood at -$4.2 million in 2020, then tumbled by 179.37% to -$11.6 million in 2021, then grew by 18.7% to -$9.4 million in 2022, then grew by 13.43% to -$8.2 million in 2023.
- Its EBT was -$8.2 million in Q4 2023, compared to -$9.4 million in Q3 2023 and -$9.0 million in Q2 2023.